The Water Supply (Water Quality) Regulations 2010 (revoked)
W.S.I. 2010/994 · Made 25 March 2010 · Extends to England and Wales
WATER, ENGLAND AND WALES
Made 25 March 2010
Laid before Parliament 30 March 2010
Laid before National Assembly for Wales 30 March 2010
Coming into force 20 April 2010
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
- F1
Regulations revoked (15.6.2018) by The Water Supply (Water Quality) Regulations 2018 (S.I. 2018/647), reg. 1(1), Sch. 6 (with reg. 39)
Contents
- Part I: General Repealed
- 1Title, commencement and application Repealed
- 2Interpretation Repealed
- Part II: Water Supply Zones Repealed
- 3Water supply zones Repealed
- Part III: Wholesomeness Repealed
- 4Wholesomeness Repealed
- Part IV: Monitoring of Water Supplies Repealed
- 5Interpretation and application of Part IV Repealed
- 6Monitoring: general provisions Repealed
- 6AMonitoring: radioactive substances Repealed
- 7Sampling points Repealed
- 8Authorisation of supply points Repealed
- 9Numbers of samples Repealed
- 10Sampling: further provisions Repealed
- Part V: Monitoring – Additional Provisions Repealed
- 11Interpretation of Part V Repealed
- 12Sampling for particular substances and parameters Repealed
- 13Sampling at treatment works Repealed
- 14Sampling at service reservoirs Repealed
- 15Sampling: new sources Repealed
- 16Collection and analysis of samples Repealed
- Part VI: Drinking Water Protected Areas Repealed
- 17Drinking water abstraction points: monitoring sites Repealed
- Part VII: Investigations, Authorisation of Departures and Remedial Action Repealed
- 18Investigations: Schedule 1 parameters Repealed
- 19Investigations: indicator parameters Repealed
- 20Action by Welsh Ministers Repealed
- 21Failure attributable to domestic distribution system where water is supplied to the public Repealed
- 22Authorisation of temporary supply of water that is not wholesome Repealed
- 23Authorisations: terms and conditions Repealed
- 24Authorisations: other limitations Repealed
- 25Publicity for authorisations Repealed
- 26Revocation and modification of authorisations Repealed
- Part VIII: Water Treatment Repealed
- 27Disinfection and other treatment arrangements Repealed
- 28Risk assessment Repealed
- 29Procedure following risk assessment and prohibition of supply Repealed
- 30Contamination from pipes Repealed
- 31Application and introduction of substances and products Repealed
- 32Use of processes Repealed
- 33Offences Repealed
- Part IX: Records and Information Repealed
- 34Maintenance of records Repealed
- 35Provision of information Repealed
- Part X: Functions of Local Authorities in Relation to Water Quality Repealed
- 36Application and interpretation Repealed
- 37Duties of local authorities: supplementary provision Repealed
- Part XI: Enforcement Repealed
- 38Contraventions by relevant suppliers Repealed
- Part XII: Revocation of Regulations Repealed
- 39Revocation of Regulations Repealed
- Signature
- Schedule 1PRESCRIBED CONCENTRATIONS AND VALUES Repealed
- Schedule 2INDICATOR PARAMETERS Repealed
- Schedule NonBreakingSpace2ARadioactive substances parameters Repealed
- Schedule 3: MONITORING Repealed
- Part Table 1: Parameters and Circumstances for Check Monitoring Repealed
- Part Table 2: Annual Sampling Frequencies: Water Supply Zones Repealed
- Part Table 3: Annual Sampling Frequencies: Treatment Works or Supply Points Repealed
- Schedule NonBreakingSpace3A: Monitoring of radioactive substances Repealed
- 1Radon Repealed
- 2Tritium Repealed
- 3Indicative Dose Repealed
- 4Water treatment Repealed
- 5Averaging Repealed
- Schedule 4: ANALYTICAL METHODOLOGY Repealed
- Part Table A1: Parameters for which, Subject to Regulation 16(7), Methods of Analysis are Prescribed Repealed
- Table A2Parameters for which, Subject to Regulation 16(7), Methods of Analysis are Prescribed Repealed
- Schedule NonBreakingSpace5: Monitoring for indicative dose and analytical performance characteristics Repealed
- 1Monitoring for compliance with the indicative dose Repealed
- 2Monitoring for compliance with the indicative dose Repealed
- 3Screening for certain radionuclides, or screening for an individual radionuclide Repealed
- 4Screening for certain radionuclides, or screening for an individual radionuclide Repealed
- 5Screening strategies for gross alpha activity and gross beta activity Repealed
- 6Screening strategies for gross alpha activity and gross beta activity Repealed
- 7Screening strategies for gross alpha activity and gross beta activity Repealed
- 8Screening strategies for gross alpha activity and gross beta activity Repealed
- 9Calculation of the indicative dose Repealed
- 10Calculation of the indicative dose Repealed
- 11Performance characteristics and methods of analysis Repealed
- Explanatory note
1Title, commencement and applicationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2InterpretationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Water supply zonesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4WholesomenessF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Interpretation and application of Part IVF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6Monitoring: general provisionsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6AMonitoring: radioactive substancesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7Sampling pointsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8Authorisation of supply pointsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9Numbers of samplesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10Sampling: further provisionsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11Interpretation of Part VF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12Sampling for particular substances and parametersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13Sampling at treatment worksF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14Sampling at service reservoirsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15Sampling: new sourcesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16Collection and analysis of samplesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17Drinking water abstraction points: monitoring sitesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18Investigations: Schedule 1 parametersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19Investigations: indicator parametersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20Action by Welsh MinistersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
21Failure attributable to domestic distribution system where water is supplied to the publicF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22Authorisation of temporary supply of water that is not wholesomeF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
23Authorisations: terms and conditionsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
24Authorisations: other limitationsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
25Publicity for authorisationsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
26Revocation and modification of authorisationsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
27Disinfection and other treatment arrangementsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
28Risk assessmentF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29Procedure following risk assessment and prohibition of supplyF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30Contamination from pipesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
31Application and introduction of substances and productsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
32Use of processesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
33OffencesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
34Maintenance of recordsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
35Provision of informationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
36Application and interpretationF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
37Duties of local authorities: supplementary provisionF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
38Contraventions by relevant suppliersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
39Revocation of RegulationsF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Signature
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule 1PRESCRIBED CONCENTRATIONS AND VALUESF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule 2INDICATOR PARAMETERSF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule NonBreakingSpace2ARadioactive substances parametersF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1RadonF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2TritiumF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Indicative DoseF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4Water treatmentF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5AveragingF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table A2Parameters for which, Subject to Regulation 16(7), Methods of Analysis are PrescribedF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Monitoring for compliance with the indicative doseF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2Monitoring for compliance with the indicative doseF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3Screening for certain radionuclides, or screening for an individual radionuclideF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4Screening for certain radionuclides, or screening for an individual radionuclideF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Screening strategies for gross alpha activity and gross beta activityF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6Screening strategies for gross alpha activity and gross beta activityF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7Screening strategies for gross alpha activity and gross beta activityF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8Screening strategies for gross alpha activity and gross beta activityF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9Calculation of the indicative doseF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10Calculation of the indicative doseF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11Performance characteristics and methods of analysisF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Explanatory note
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .